Interestingly, EFNA1 was shown to mediate dopaminergic neurogenesis and angiogenesis in a rat model of PD, and its activation proposed as a potential target for the treatment of neurodegenerative diseases76. This evidence concerns the gene EFNA1 and Parkinson disease.